Connection
Matthew Greenhawt to Health Care Costs
This is a "connection" page, showing publications Matthew Greenhawt has written about Health Care Costs.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
2.238 |
|
|
|
-
Shaker M, Greenhawt M. Common Sense in Dollars and Cents: Context Matters in Cost-Effectiveness Checklist Evaluations. Value Health. 2022 08; 25(8):1459-1460.
Score: 0.625
-
Shaker M, Chalil JM, Tran O, Vlahiotis A, Shah H, King T, Green TD, Greenhawt M. Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy. Ann Allergy Asthma Immunol. 2020 04; 124(4):357-365.e1.
Score: 0.541
-
Shaker M, Wallace D, Golden DBK, Oppenheimer J, Greenhawt M. Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis. JAMA Netw Open. 2019 10 02; 2(10):e1913951.
Score: 0.530
-
Shaker MS, Greenhawt MJ. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. JAMA Pediatr. 2019 02 01; 173(2):169-175.
Score: 0.507
-
Iglesia EGA, Greenhawt M, Shaker MS. Achieving the Quadruple Aim to deliver value-based allergy care in an ever-evolving health care system. Ann Allergy Asthma Immunol. 2020 08; 125(2):126-136.
Score: 0.034